Mundipharma Pharmaceuticals Ltd is pleased to announce the launch of Targin 15/7.5mg and 30/15mg prolonged-release tablets (15/7.5mg and 30/15mg oxycodone/naloxone). Targin contains the opioid analgesic oxycodone and is indicated for the treatment of severe pain, which can be adequately managed only with opioid analgesics. A recognised side-effect of opioid treatment is opioid-induced constipation (OIC). The severity of OIC experienced can lead to patients reducing their dose of medication or ceasing treatment completely. Targin is designed to reduce this problem with the addition of the opioid antagonist naloxone which is added to counteract OIC by blocking the action of oxycodone at